A Phylogenetic Analysis of Hepatitis C Virus Transmission, Relapse, and Reinfection Among People Who Inject Drugs Receiving Opioid Agonist Therapy
Author(s) -
Matthew J. Akiyama,
Daniel Lipsey,
Lilia GanovaRaeva,
Lili Punkova,
Linda Agyemang,
Amanda Sue,
Sumathi Ramachandran,
Yury Khudyakov,
Alain H. Litwin
Publication year - 2020
Publication title -
the journal of infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.69
H-Index - 252
eISSN - 1537-6613
pISSN - 0022-1899
DOI - 10.1093/infdis/jiaa100
Subject(s) - medicine , transmission (telecommunications) , harm reduction , cohort , psychological intervention , hypervariable region , hepatitis c virus , virology , viral load , hepatitis c , outbreak , immunology , virus , psychiatry , antibody , human immunodeficiency virus (hiv) , electrical engineering , engineering
Understanding hepatitis C virus (HCV) transmission among people who inject drugs (PWID) is essential for HCV elimination. We aimed to differentiate reinfections from treatment failures and to identify transmission linkages and associated factors in a cohort of PWID receiving opioid agonist therapy (OAT).
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom